1. Cell Biology
Download icon

Bardet–Biedl syndrome 3 protein promotes ciliary exit of the signaling protein phospholipase D via the BBSome

  1. Yan-Xia Liu
  2. Bin Xue
  3. Wei-Yue Sun
  4. Jenna L Wingfield
  5. Jun Sun
  6. Mingfu Wu
  7. Karl F Lechtreck
  8. Zhenlong Wu
  9. Zhen-Chuan Fan  Is a corresponding author
  1. State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, China
  2. Department of Cellular Biology, University of Georgia, United States
  3. Department of Molecular and Cellular Physiology, Albany Medical College, United States
  4. State Key Laboratory of Animal Nutrition, China Agricultural University, China
Research Article
  • Cited 6
  • Views 1,085
  • Annotations
Cite this article as: eLife 2021;10:e59119 doi: 10.7554/eLife.59119

Abstract

Certain ciliary signaling proteins couple with the BBSome, a conserved complex of Bardet–Biedl syndrome (BBS) proteins, to load onto retrograde intraflagellar transport (IFT) trains for their removal out of cilia in Chlamydomonas reinhardtii. Here, we show that loss of the Arf-like 6 (ARL6) GTPase BBS3 causes the signaling protein phospholipase D (PLD) to accumulate in cilia. Upon targeting to the basal body, BBSomes enter and cycle through cilia via IFT, while BBS3 in a GTP-bound state separates from BBSomes, associates with the membrane, and translocates from the basal body to cilia by diffusion. Upon arriving at the ciliary tip, GTP-bound BBS3 binds and recruits BBSomes to the ciliary membrane for interacting with PLD, thus making the PLD-laden BBSomes available to load onto retrograde IFT trains for ciliary exit. Therefore, BBS3 promotes PLD exit from cilia via the BBSome, providing a regulatory mechanism for ciliary signaling protein removal out of cilia.

Introduction

The cilium consists of a microtubule-based axoneme surrounded by a specialized ciliary membrane and is assembled relying on motor-driven intraflagellar transport (IFT) trains, which consist of repeating units of the multiprotein complexes IFT-A and IFT-B (composed of IFT-B1 and -B2 subcomplexes) and traffic along the axoneme (Cole et al., 1998; Follit et al., 2009; Kozminski et al., 1993; Lucker et al., 2005; Nachury, 2018; Ou et al., 2007; Pigino et al., 2009; Taschner et al., 2014; Taschner et al., 2016). As a signaling hub, the cilium senses and transmits extracellular stimuli inside the cell through ciliary signaling proteins, including G protein-coupled receptors (GPCRs), ion channels, and others such as phospholipase D (PLD) and AMP-activated protein kinase (Berbari et al., 2008; Datta et al., 2015; Domire et al., 2011; Liu and Lechtreck, 2018; Siljee et al., 2018; Valentine et al., 2012; Zhang et al., 2012). These membrane proteins cycle between cell membrane and ciliary membrane via IFT (Kozminski et al., 1993; Nachury, 2018; Pigino et al., 2009). During this process, the octameric BBSome, composed of eight Bardet–Biedl syndrome (BBS) proteins (BBS1/2/4/5/7/8/9/18), acts as an IFT adaptor to link specific ciliary signaling proteins to IFT trains for their transport in and/or out of the cilium (Bhogaraju et al., 2013; Eguether et al., 2014; Lechtreck et al., 2009; Liew et al., 2014; Liu and Lechtreck, 2018; Nachury, 2018; Nachury et al., 2007; Ruat et al., 2012; Su et al., 2014; Zhang et al., 2012). Therefore, defects in assembly and composition of the BBSome or factors required for mediating ciliary cycling of the BBSome lead to loss and/or abnormal accumulation of signaling proteins in the ciliary membrane (Chiang et al., 2004; Lechtreck et al., 2009; Loktev et al., 2008; Nachury et al., 2007; Scheidecker et al., 2014; Zhang et al., 2011). This eventually causes improper ciliary signaling and results in BBS, a human inherited ciliopathic disorder characterized by multiorgan dysfunction such as retinal dystrophy, male infertility, polydactyly, early-onset obesity, and renal failure in some cases (Fliegauf et al., 2007).

The BBSome performs IFT-dependent ciliary cycling in four continuous steps: coupling with IFT at the ciliary base, entry and anterograde traffic (from the base to the tip), remodeling and turnaround at the ciliary tip, and retrograde traffic (from the tip to the base) and ciliary exit (Eguether et al., 2014; Iomini et al., 2001; Keady et al., 2012; Lechtreck et al., 2013; Liew et al., 2014; Pedersen et al., 2006; Pedersen et al., 2005; Wei et al., 2012). During this process, BBSome cargoes, such as somatostatin receptor 3 (Ssr3) and melanin-concentrating hormone receptor 1 (Mchr1), couple with the BBSome at the ciliary base for ciliary entry (Berbari et al., 2008; Jin et al., 2010). In contrast, others like dopamine receptor 1 (D1), GPR161, and PLD load onto the BBSome at the ciliary tip for ciliary exit (Domire et al., 2011; Liew et al., 2014; Liu and Lechtreck, 2018; Ye et al., 2018). It was shown that the BBSome is recruited from the cell body to the ciliary base as the major effector of the Arf-like 6 (ARL6) GTPase BBS3 (Jin et al., 2010; Xue et al., 2020). Such a scenario could allow cells to control the amount of BBSomes available at the basal body and in turn regulate the presence and amount of signaling protein cargoes in the ciliary membrane (Jin et al., 2010; Xue et al., 2020). When in its GTP-bound state, BBS3 enters cilia (Liew et al., 2014; Xue et al., 2020) and undergoes GTPase cycling (Liew et al., 2014). Upon finishing a GTPase cycle with the aid of the Rab-like 4 (RABL4) GTPase IFT27 as a BBS3-specific guanine nucleotide exchange factor (GEF), GTP-loaded BBS3 mimics its role in the cell body to bind the cargo-laden BBSomes at the ciliary tip and loads cargoes onto retrograde IFT trains for ciliary exit, thus regulating the cargo content in the ciliary membrane (Liew et al., 2014). Currently, the precise molecular activity by which BBS3 maintains the ciliary dynamics of signaling protein cargoes through the BBSome remains to be determined, while both in vitro biochemical analysis and structural studies have implicated that membrane association of BBS3 in its active GTP-bound state is a prerequisite for signaling protein cargoes to couple with BBSomes (Jin et al., 2010; Liew et al., 2014; Loktev et al., 2008; Mourão et al., 2014; Nachury et al., 2007).

Our current limited understanding of how BBS3 and the BBSome interact for regulating signaling protein content in the ciliary membrane was derived mainly from biochemical assays performed on whole-cell extracts but not ciliary extracts of mammalian cells (Jin et al., 2010; Liew et al., 2014). Chlamydomonas reinhardtii has a clear advantage over other ciliated model organisms as its cilia can be easily isolated for biochemical analysis. Hence, we explored how BBS3 and the BBSome cross-talk in C. reinhardtii for targeting to the basal body, for entering cilia from the basal body, and for maintaining their dynamics in cilia and how they coordinate to mediate ciliary exit of PLD in C. reinhardtii (Liu and Lechtreck, 2018). By performing functional, in vivo biochemical, and single-particle in vivo imaging assays, we showed that the BBSome depends on BBS3 for targeting to the basal body but not vice versa. Upon targeting to the basal body, GTP-bound BBS3 separates from the BBSome and they enter cilia by diffusion (BBS3) and via IFT (the BBSome). Upon reaching the ciliary tip, BBS3 mediates the sorting of PLD out of cilia through promoting its coupling with the BBSome, thus filling a gap in our understanding of how BBS3 regulates ciliary removal of signaling proteins through the BBSome in C. reinhardtii.

Results

BBS3 is not required for the BBSome to enter cilia from the basal body

It was previously reported that the BBSome relies on BBS3 for entering cilia in human cells (Jin et al., 2010). Our previous study showed that Chlamydomonas BBS3 is actually required for recruiting the BBSome to the basal body, thus making the BBSome available for loading onto anterograde IFT trains for ciliary entry (Xue et al., 2020). This finding raises the question of whether the BBSome, upon targeting to the basal body, requires BBS3 for entering cilia. To answer this question, we examined the so-called BBS3 CLiP mutant (LMJ.RY0402.149010) that we named clip1. The clip1 strain contains a 1923 bp paromomycin gene insertion in 3' distal region of the fifth intron of the BBS3 gene (Figure 1—figure supplement 1A–C). This insertion does not cause changes in BBS3 cDNA sequence (Figure 1—figure supplement 1D, E), and the endogenous BBS3 and the BBSome subunits BBS1 and BBS5 were maintained at wild-type levels (Figure 1A), demonstrating that the clip1 strain is not a real BBS3-null mutant. Strikingly, BBS3 was not present in cilia of the clip1 strain, while BBS1 and BBS5 were maintained at wild-type levels in cilia, a result showing that the BBSome does not require BBS3 for entering cilia (Figure 1B). To verify that BBS3 is not able to enter cilia in clip1 cells, we expressed BBS3 attached at its C-terminus to a yellow fluorescent protein (YFP) (BBS3::YFP) in wild-type CC-5325 and clip1 cells (resulting strains BBS3::YFP5325 and BBS3::YFPclip1) (Figure 1C). The transgenic BBS3::YFP, similar to the endogenous BBS3, was present in cilia of BBS3::YFP5325 cells but not of BBS3::YFPclip1 cells (Figure 1D, E). As expected, BBS1 and BBS5 were maintained at wild-type levels in whole-cell samples and cilia of both strains (Figure 1C, D). In addition, BBS5 and BBS3::YFP were concentrated and colocalized at the basal bodies in both BBS3::YFP5325 and BBS3::YFPclip1 cells (Figure 1E), and BBS3::YFP immunoprecipitated BBS1 and BBS5 in the cell body extracts of BBS3::YFPclip1 cells (Figure 1F), suggesting that BBS3 retains its ability to bind and recruit the BBSome to the basal body in clip1 cells (Xue et al., 2020). Thus, it remains to be investigated why BBS3 concentrates at the basal bodies but is prevented from entering cilia in clip1 cells, while our data clearly show that Chlamydomonas BBS3 is not required for entry of the BBSome into cilia from the basal bodies (Figure 1G). This notion was confirmed when BBS3 knockdown and rescue studies were performed (Figure 7D, E).

Figure 1 with 1 supplement see all
Download asset Open asset
BBS3 is not required for the BBSome to enter cilia from the basal body.

(A and B) Immunoblots of whole-cell extracts (WCE) (A) and ciliary extracts (CE) (B) of CC-5325 and clip1 cells probed for BBS3, BBS1, and BBS5. (C and D) Immunoblots of WCE (C) and CE (D) of CC-5325, BBS3::YFP5325, and BBS3::YFPclip1 cells probed with α-BBS3, α-BBS1, and α-BBS5. MW: molecular weight. (E) BBS3::YFP5325 and BBS3::YFPclip1 cells stained with α-YFP (green) and α-BBS5 (red). Inset shows the basal bodies. White arrows show ciliary staining. Scale bar 10 µm. (F) Immunoblots of α-YFP captured proteins from cell body extracts (CBE) of HR-YFP (YFP-expressing CC-125 cells) and BBS3::YFPclip1 cells probed with α-BBS1 and α-BBS5. Input was quantified with α-YFP by immunoblotting. (G) Schematic presentation showing that the BBSome migrates from the basal body into cilia via IFT in a BBS3-independent manner. For immunoblotting, α-tubulin and acetylated-tubulin (Ac-tubulin) were used to adjust the loading of WCE and CE, respectively.

BBS3 enters cilia without relying on the BBSome

It was previously reported that BBS3 relies on the BBSome for entering cilia in human cells (Jin et al., 2010). To investigate whether this applies in C. reinhardtii, we examined the BBS1-null bbs1-1 mutant (Lechtreck et al., 2009), in which protein levels of BBS3 and the BBSome subunits BBS4, BBS5, and BBS7 were at wild-type levels (Figure 2A; and Figure 2—figure supplement 1). These BBSome proteins were not present in cilia of bbs1-1 cells (Figure 2B), and BBS5 was also absent from the basal bodies in bbs1-1 cells (Figure 2C), indicating that knockout of BBS1 disrupts BBSome assembly and no BBSome is available to be recruited to the basal body for ciliary entry in bbs1-1 cells. Of note, BBS3 was concentrated at the basal bodies and distributed along the length of cilia in bbs1-1 cells (Figure 2D). Together with the result that BBS3 is present in cilia of bbs1-1 cells at wild-type level (Figure 2B), our data revealed that Chlamydomonas BBS3 does not require the BBSome for targeting to the basal body nor for entering cilia. Our previous study revealed that the BBSome loads onto anterograde IFT trains at the basal body and enters cilia via IFT in C. reinhardtii (Xue et al., 2020). In mammalian cells, BBS3 binds the BBSome through a direct interaction between BBS3 and BBS1 (Mourão et al., 2014) and was proposed to enter cilia via IFT through binding the BBSome (Jin et al., 2010; Liew et al., 2014). Since Chlamydomonas BBS3 can enter cilia without relying on the BBSome, we proposed that BBS3 does not enter cilia via IFT in C. reinhardtii. Supportive of this notion, when expressed at similar levels in CC-125 and bbs1-1 cells (resulting strains BBS3::YFP and BBS3::YFP1-1) (Figure 2E), BBS3::YFP entered cilia of both strains and was maintained in cilia of both strains at similar amounts (Figure 2F). As reflected by total internal reflection fluorescence (TIRF) imaging, BBS3::YFP statically distributed along the length of cilia but did not undergo IFT in either strain (Figure 2G; and Figure 2—videos 1 and 2). Thus, BBS3 can enter cilia independent of the BBSome and does not traffic bidirectionally in cilia via IFT but likely diffuses inside cilia (Figure 2H).

Figure 2 with 3 supplements see all
Download asset Open asset
BBS3 enters cilia without relying on the BBSome.

(A and B) Immunoblots of whole-cell extracts (WCE) (A) and ciliary extracts (CE) (B) of CC-125 and bbs1-1 cells probed for BBS3 and the BBSome subunits BBS1, BBS4, BBS5, and BBS7. (C and D) CC-125 and bbs1-1 cells stained with α-BBS5 (red) (C) and α-BBS3 (red) (D). The corresponding phase contrast images are present. Inset shows the basal bodies. White arrows show ciliary staining. Scale bar 10 µm. (E and F) Immunoblots of WCE (E) and CE (F) of CC-125, BBS3::YFP (BBS3::YFP-expressing CC-125 cells), and BBS3::YFP1-1 (BBS3::YFP-expressing bbs1-1 cells) cells probed with α-BBS3. (G) Total internal reflection fluorescence images and corresponding kymograms of BBS3::YFP and BBS3::YFP1-1 cells (Figure 2—videos 1 and 2, 15 fps). The time and transport lengths are indicated on the right and on the bottom, respectively. (H) Schematic presentation showing that BBS3 can traffic from the cell body to the basal body for entering cilia in a BBSome-independent manner. For panels A, B, E, and F, α-tubulin and Ac-tubulin were used to adjust the loading of WCE and CE, respectively.

Membrane association is a prerequisite for BBS3 to enter cilia

Other studies have demonstrated that GTP-loaded small GTPase of the Arf family associates with the membrane via its N-terminal amphipathic helix (Amor et al., 1994; Liu et al., 2010; Zhang et al., 2011), and the N-terminal residues 1–15 are essential for BBS3 to associate with the membrane in vitro (Jin et al., 2010; Mourão et al., 2014). When incubated with the synthetic liposomes, bacterially expressed BBS3::YFP associated with liposomes only in the presence of GTPγS, which locks BBS3::YFP in a GTP-bound state (Figure 3A, B; Liew et al., 2014). In contrast, BBS3△N::YFP, which lacks the N-terminal residues 1–15 of BBS3, did not associate with liposomes even in the presence of GTPγS, revealing that the N-terminal amphipathic helix is required for BBS3 to associate with the membrane, and BBS3 associates with the membrane in a GTP-dependent manner (Figure 3A, B). To examine whether the N-terminal residues 1–15 are essential for BBS3 to enter cilia in vivo, we expressed BBS3△N::YFP at similar levels in CC-125 and bbs1-1 cells (resulting strains BBS3△N::YFP and BBS3△N::YFP1-1) (Figure 3C). In contrast to BBS3::YFP that enters cilia of both CC-125 and bbs1-1 cells (Figure 2F, G), BBS3△N::YFP was absent from cilia of both BBS3△N::YFP and BBS3△N::YFP1-1 strains (Figure 3D, E), indicating that depletion of the N-terminal residues 1–15 prevents BBS3 from entering cilia. Of note, BBS3△N::YFP was concentrated at the basal bodies of both BBS3△N::YFP and BBS3△N::YFP1-1 strains, revealing that depletion of the N-terminal residues 1–15 retains the ability of BBS3 to traffic from the cell body to the basal body in a BBSome-independent manner (Figure 3E). In BBS3△N::YFP1-1 cells, the BBSome was not assembled due to the lack of BBS1 and thus was not available for targeting to the basal bodies for ciliary entry (Figure 3D, E). In contrast, BBS3△N::YFP colocalized with BBS5 at the basal bodies in BBS3△N::YFP cells (Figure 3E) and immunoprecipitated the BBSome subunits BBS1 and BBS5 in the cell body extracts of BBS3△N::YFP cells (Figure 3F), revealing that BBS3△N::YFP retains the ability to bind and recruit the BBSome to the basal body (Xue et al., 2020). Therefore, loss of the N-terminal residues 1–15 of BBS3 does not prevent BBS3 from binding and targeting the BBSome to the basal body, while membrane association is necessary for BBS3 to enter cilia from the basal body in C. reinhardtii (Figure 3G).

Figure 3
Download asset Open asset
Membrane association is a prerequisite for BBS3 to enter cilia.

(A) Schematic presentation of BBS3::YFP and BBS3△N::YFP. △N: N-terminal 15 amino acids of BBS3 deleted. (B) SDS-PAGE visualization of bacterially expressed BBS3::YFP and BBS3△N::YFP and immunoblots of liposome-incubated BBS3::YFP and BBS3△N::YFP in the presence of GTPγS, GDP, or neither probed with α-BBS3. (C and D) Immunoblots of whole-cell extracts (WCE) (C) and ciliary extracts (CE) (D) of CC-125, BBS3△N::YFP (BBS3△N::YFP-expressing CC-125 cells), and BBS3△N::YFP1-1 (BBS3△N::YFP-expressing bbs1-1 cells) cells probed with α-BBS3, α-BBS1, and α-BBS5. α-tubulin and Ac-tubulin were used to adjust the loading of WCE and CE, respectively. (E) BBS3△N::YFP and BBS3△N::YFP1-1 cells stained with α-YFP (green) and α-BBS5 (red). The corresponding phase contrast images are present. Inset shows the basal bodies. White arrows show ciliary staining. Scale bar 10 µm. (F) Immunoblots of α-YFP-captured proteins from cell body extracts (CBE) of BBS3::YFP, BBS3△N::YFP, and BBS3△N::YFP1-1 cells probed with α-BBS1, α-BBS4, α-BBS5, and α-BBS7. Input was quantified with α-YFP by immunoblotting. (G) Schematic presentation of how BBS3 translocates from the basal bodies to cilia on the membrane.

BBS3 associates with the ciliary membrane in a GTP-dependent manner

BBS3 of several species is unique in that they contain an alanine (73A for C. reinhardtii) rather than a glutamine (Q) residue at the position critical for Ras family GTPases to hydrolyze GTP (Figure 4—figure supplement 1A). Among them, Chlamydomonas BBS3 has been examined to be an active GTPase but with low intrinsic GTPase activity (Mourão et al., 2014). Both in vitro biochemical and in vivo functional experiments demonstrated that BBS3T31R is a GDP-locked (inactive) variant (Figure 4—figure supplement 1A, B; Kobayashi et al., 2009; Wiens et al., 2010; Xue et al., 2020). A73L mutation disrupted BBS3 GTP hydrolysis, suggesting that BBS3A73L is a GTP-locked constitutively positive variant (Figure 4—figure supplement 1A, B; and Figure 4—figre supplement 1—source data 1; Liew et al., 2014). Our previous study has revealed that BBS3 in its GTP-bound form (BBS3A73L) binds and recruits the BBSome to the basal body for entering cilia (Xue et al., 2020). When expressed in CC-125 cells (resulting strain BBS3A73L::YFP) (Figure 4A), BBS3A73L::YFP, like BBS3::YFP, is present in cilia (Figure 4B, C) and appears statically distributed along the length of cilia as reflected by TIRF imaging (Figure 4C; and Figure 4—videos 1 and 2). Similar stationary pattern was also recorded for the C-terminal green fluorescent protein (GFP)-tagged BBS3 and the A73L mutant in rescuing strains BBS3Res-WT and BBS3Res-A73L, in which BBS3::GFP and BBS3A73L::GFP are expressed in similar amounts in the BBS3-knockdown strain BBS3miRNA (Figure 4D; and Figure 4—videos 3 and 4; Xue et al., 2020). Upon entering cilia, BBS3A73L::YFP was detected in the membrane fraction but not in the matrix fraction isolated from cilia of the BBS3A73L::YFP strain, while the majority of BBS3::YFP was present in the matrix faction of cilia of the BBS3::YFP strain (Figure 4E; and Figure 4—figure supplement 2). To confirm this observation, we performed ciliary fraction analysis on CC-125 cells in the presence of GTPγS, GDP, or neither, which are proposed to lock BBS3 at a GTP-bound, GDP-bound, or wild-type state, respectively (Liew et al., 2014). Our data showed that BBS3 is mainly present in the matrix fraction in the absence of nucleotide or completely present in the matrix fraction when GDP was added, while the majority of BBS3 was detected in the membrane faction in the presence of GTPγS (Figure 4F). Therefore, GTP binding allows BBS3 to attach to the ciliary membrane, and GDP binding detaches BBS3 from the ciliary membrane in cilia, consistent with the observation that GTP- but not GDP-bound BBS3 associates with the membrane of liposomes in vitro (Figure 3B; Mourão et al., 2014).

Figure 4 with 6 supplements see all
Download asset Open asset
BBS3 associates with the ciliary membrane in a GTP-dependent manner.

(A and B) Immunoblots of whole-cell extracts (WCE) (A) and ciliary extracts (CE) (B) of CC-125, BBS3::YFP, and BBS3A73L::YFP cells probed with α-BBS3. α-tubulin and Ac-tubulin were used to adjust the loading of WCE and CE, respectively. (C and D) Total internal reflection fluorescence images and corresponding kymograms of BBS3::YFP and BBS3A73L::YFP cells (Figure 4—videos 1 and 2, 15 fps) (C), and BBS3Res-WT and BBS3Res-A73L cells (Figure 4—videos 3 and 4, 15 fps) (D). The time and transport lengths are indicated on the right and on the bottom, respectively. (E) Immunoblots of flagella and ciliary membrane and matrix fractions of BBS3::YFP and BBS3A73L::YFP cells probed with α-BBS3, α-IFT57, and α-PLD. (F) Immunoblots of flagella and ciliary membrane and matrix fractions of CC-125 cells, in the presence of GTPγS, GDP, or neither, probed for BBS3, IFT57, and PLD. For panels E and F, IFT57 is solely present in the ciliary matrix fraction, while PLD is only detected in the ciliary membrane fraction.

BBS3 interacts with the BBSome in cilia in a GTP-dependent manner

Rodent BBS3, in its GTP-bound state, binds and recruits the BBSome to the membrane of liposomes in vitro, implying that, in cilia, GTP loading confers BBS3 to bring the BBSome to the ciliary membrane (Liew et al., 2014). To investigate whether and how BBS3 interacts with the BBSome in cilia of C. reinhardtii cells, we performed sucrose gradient density centrifugation on the ciliary extracts of BBS3::YFP and BBS3A73L::YFP transgenic strains. Of note, a minority of BBS3::YFP co-sedimented with the BBSome subunits BBS1 and BBS5 (Figure 5A). In contrast, the majority of BBS3A73L::YFP co-sedimented with the two BBSome proteins although partial BBS3A73L::YFP remained to be existing as a free form independent of the two BBSome proteins in cilia (Figure 5A). These results showed that GTP-loaded BBS3 is able to bind the BBSome in cilia (Figure 5A). This notion was confirmed by observing that the BBS3A73L variant but not BBS3::YFP recovered BBS1 and BBS5 in the ciliary extracts (Figure 5B). To further verify this result, we added GTPγS or GDP, which is proposed to lock GTPases in a GTP- or GDP-bound state, respectively, to the ciliary extracts of BBS3::YFP cells (Liew et al., 2014). Sucrose gradient density centrifugation assay identified BBS3::YFP sediments separately from BBS1 and BBS5 in the presence of GDP but became partially co-sedimented with the two BBSome proteins when GTPγS was present (Figure 5C). Together with the observation that BBS3::YFP immunoprecipitated BBS1 and BBS5 in the ciliary extracts of the BBS3::YFP transgenic strain only when GTPγS was present (Figure 5D), we concluded that BBS3 in a GTP- but not GDP-bound configuration binds the BBSome in cilia. Of note, partial BBS3, even when locked in a GTP-bound configuration, remained not to interact with the BBSome, revealing that GTP loading cannot confer all BBS3 molecules to interact with the BBSome in cilia (Figure 5A, C).

Figure 5
Download asset Open asset
BBS3 interacts with the BBSome in cilia in a GTP-dependent manner.

(A) Immunoblots of sucrose density gradient of ciliary extracts (CE) of BBS3::YFP and BBS3A73L::YFP cells probed with α-BBS1, α-BBS5, and α-YFP. (B) Immunoblots of α-YFP-captured proteins from CE of BBS3A73L::YFP and BBS3::YFP cells probed with α-BBS1 and α-BBS5. (C) Immunoblots of sucrose density gradient of CE of BBS3::YFP cells, in the presence of GTPγS or GDP, probed with α-BBS1, α-BBS5, and α-GFP. (D) Immunoblots of α-YFP-captured proteins from CE of BBS3::YFP cells, in the presence of GTPγS, GDP, or neither, probed with α-BBS1 and α-BBS5. For panels B and D, input was quantified with α-YFP by immunoblotting.

The BBSome cycles through cilia normally in the absence of BBS3 in cilia

Once at the ciliary tip, the BBSome/IFT train is proposed to remodel before undergoing turnaround to exit cilia (Wei et al., 2012). During this process, rodent BBS3 was reported to mediate BBSome exit out of cilia by promoting its loading onto retrograde IFT trains at the ciliary tip (Liew et al., 2014). To investigate whether this applies in C. reinhardtii, we examined clip1 cells and found that loss of BBS3 in cilia did not cause ciliary hyperaccumulation of the BBSome subunits BBS1, BBS4, BBS5, and BBS7, excluding BBS3 from being required for the BBSome to exit cilia in C. reinhardtii (Figure 6A and Figure 1B; Liew et al., 2014). Our previous study has shown that loss of IFT25 blocks loading of the BBSome onto retrograde IFT trains (Dong et al., 2017b). Reflecting this observation, BBS1 and BBS5 hyperaccumulated at the ciliary tip in the IFT25-knockdown cells (Figure 6B). BBS1 and BBS5 co-sedimented with each other and peaked at the same fraction as IFT-B1 (checked with IFT46 and IFT70) in the ciliary extracts of wild-type CC-5325 cells (Figure 6C; Xue et al., 2020). In contrast, these two BBSome proteins rather than IFT-B1 were found to shift to lower fractions in the ciliary extracts of IFT25miRNA cells, suggesting that they are not able to assemble to form intact BBSomes after remodeling at the ciliary tip (Figure 6C). As compared to the IFT25-knockdown cells, clip1 cells did not accumulate BBS1 and BBS5 at the ciliary tip and the two BBSome subunit proteins co-sedimented in the same fractions as IFT-B1 in the ciliary extracts of clip1 cells, demonstrating that ciliary dynamics of the BBSome is normally maintained when BBS3 is absent from cilia (Figure 6B, C). These results further argued against BBS3 being required for the BBSome to load onto retrograde IFT trains for ciliary exit (Liew et al., 2014). Next, we expressed BBS5::YFP in similar amounts in CC-5325 and clip1 cells (resulting strains BBS5::YFP5325 and BBS5::YFPclip1) (Figure 6D). BBS5::YFP entered cilia of both strains and was maintained at similar amounts (Figure 6E). As determined by TIRF imaging, BBS5::YFP underwent IFT with normal speeds and velocities in cilia of clip1 cells, suggesting that IFT of the BBSome is not impaired when BBS3 is absent from cilia (Figure 6F, G; Figure 6—source data 1; and Figure 6—videos 1 and 2). Therefore, we concluded that BBS3 is not required for maintaining BBSome dynamics in cilia, nor for promoting BBSome coupling/uncoupling with IFT trains at the ciliary tip in C. reinhardtii (Figure 6H).

Figure 6 with 2 supplements see all
Download asset Open asset
The BBSome cycles through cilia normally in the absence of BBS3 in cilia.

(A) Immunoblots of ciliary extracts (CE) of CC-5325 and clip1 cells probed for BBS3 and the BBSome subunits BBS1, BBS4, BBS5, and BBS7. Ac-tubulin was used to adjust the loading. (B) CC-5325, IFT25miRNA, and clip1 cells stained with α-BBS1 (red) and α-BBS5 (red). Inset shows ciliary tips. Scale bar 10 µm. (C) Immunoblots of sucrose density gradient of CE of CC-5325, IFT25miRNA, and clip1 probed with α-IFT46, α-IFT70, α-BBS1, and α-BBS5. (D and E) Immunoblots of whole-cell extracts (WCE) (D) and CE (E) of CC-5325, BBS5::YFP5325, and BBS5::YFPclip1 cells probed with α-BBS5. α-tubulin and Ac-tubulin were used to adjust the loading of WCE and CE, respectively. (F) Total internal reflection fluorescence images and corresponding kymograms of BBS5::YFP5325 and BBS5::YFPclip1 cells (Figure 6—videos 1 and 2, 15 fps). The time and transport lengths are indicated on the right and on the bottom, respectively. (G) Speeds and frequencies of BBS5::YFP inside cilia of BBS5::YFP5325 and BBS5::YFPclip1 cells are similar. The speeds of BBS5::YFP were 2.01 ± 0.12 (anterograde) and 3.31 ± 0.27 μm/sec (retrograde), and the frequencies were 0.69 ± 0.10 (anterograde) and 0.39 ± 0.10 particles/sec (retrograde) for BBS5::YFP5325 cells. In cilia of BBS5::YFPclip1 cells, the speeds of BBS5::YFP were 2.04 ± 0.11 (anterograde) and 3.34 ± 0.19 μm/sec (retrograde), and the frequencies were 0.70 ± 0.09 (anterograde) and 0.41 ± 0.08 particles/sec (retrograde). Error bar indicates SD. n: number of cilia analyzed; n.s.: non-significance. (H) Schematic presentation showing that the BBSome and IFT trains remodel at the ciliary tip in a BBS3-independent manner.

Figure 6—source data 1

Source data for the speed and frequency experiment shown in Figure 6G.

https://cdn.elifesciences.org/articles/59119/elife-59119-fig6-data1-v2.xlsx

BBS3 is essential for PLD to associate with the BBSome for ciliary exit

In C. reinhardtii, the membrane-associated signaling protein PLD enters cilia mostly by diffusion but is removed from cilia mainly via IFT by associating with the BBSome. Therefore, the bbs mutants accumulates PLD in cilia as the BBSome is not available for entering cilia to bridge PLD to retrograde IFT trains for ciliary exit in those mutants (Lechtreck et al., 2013; Liu and Lechtreck, 2018). Of note, the clip1 strain contained PLD at wild-type level in whole-cell sample (Figure 7A) and accumulated PLD in cilia, mostly at the ciliary tip (Figure 7B, C), revealing that BBS3 is essential for promoting PLD to exit cilia. In clip1 cells, BBS3 was maintained at wild-type level in whole-cell sample (Figure 7A) but was absent from cilia (Figure 7B), and its ciliary absence did not affect BBSome abundance in cilia and uncoupling/recoupling of the BBSome with IFT at the ciliary tip (Figure 6A–F); we thus concluded that Chlamydomonas BBS3 is essential for PLD to associate with the BBSome at the ciliary tip for ciliary exit via IFT. To further verify this notion, we examined the BBS3-knockdown strain, BBS3miRNA, in which the BBSome (checked with BBS1 and BBS5) was maintained at wild-type level in whole-cell sample but was strongly reduced in cilia (Figure 7D, E; Xue et al., 2020). BBS3 knockdown did not alter cellular PLD level but accumulated PLD in cilia, mostly at the ciliary tip (Figure 7D–F). When BBS3::GFP was expressed in BBS3miRNA cells (resulting strain BBS3Res-WT), it entered cilia and restored BBS1, BBS5, and PLD to wild-type levels (Figure 7D–F; Xue et al., 2020). When BBS3△N::YFP was expressed in BBS3miRNA cells (resulting strain BBS3Res-△N), BBS1 and BBS5 were rescued to wild-type levels in cilia, while PLD remained to be accumulated mostly at the ciliary tip (Figure 7D–F). Since BBS3 was absent from cilia of both BBS3miRNA and BBS3Res-△N cells and BBS1 and BBS5 were restored to wild-type levels in cilia of BBS3Res-△N cells, our data thus showed that ciliary absence of BBS3 causes PLD to accumulate mostly at the ciliary tip even when intact BBSomes are present in cilia (Figure 7E–G), confirming that BBS3 is essential for PLD to associate with the BBSome at the ciliary tip for ciliary exit. Remarkably, the BBS3A73L::GFP-expressing BBS3miRNA strain BBS3Res-A73L also restored the ciliary PLD content to wild-type level, excluding GTPase cycling of BBS3 in cilia from mediating PLD association with the BBSome for ciliary exit (Figure 7D–F). Together with the observation that PLD rarely co-sedimented with the BBSome (checked with BBS1 and BBS5) in the ciliary extracts of clip1 cells; a minority of PLD co-sedimented with the BBSome in the ciliary extracts of BBS3Res-△N cells; and the majority of PLD became co-sedimented with the BBSome in the ciliary extracts of BBS3Res-A73L cells (Figure 7H), our data suggest that GTP-bound BBS3 efficiently enables PLD to associate with the BBSome in cilia at the ciliary tip to undergo retrograde IFT (Figure 7I). In addition, BBS3△N::YFP did not enter cilia itself but restored BBS1 and BBS5 to wild-type levels in cilia of the BBS3-knockdown BBS3miRNA cells (Figure 7D–F), providing compelling evidence to confirm that ciliary entry of the BBSome from the ciliary base does not depend on BBS3 (Figure 1).

Figure 7
Download asset Open asset
BBS3 is essential for PLD to associate with the BBSome for ciliary exit.

(A and B) Immunoblots of whole-cell extracts (WCE) (A) and ciliary extracts (CE) (B) of CC-5325 and clip1 cells probed with α-BBS3 and α-PLD. (C) CC-5325 and clip1 cells stained with α-PLD (red). (D and E) Immunoblots of WCE (D) and CE (E) of CC-125, BBS3miRNA, BBS3Res-WT, BBS3Res-A73L, and BBS3Res-△N cells probed with α-BBS3, α-BBS1, α-BBS5, and α-PLD. (F) CC-125, BBS3miRNA, BBS3Res-WT, BBS3Res-A73L, and BBS3Res-△N cells stained with α-PLD (red). (G) Immunoblots of sucrose density gradient of CE of CC-125 and BBS3Res-△N cells probed with α-BBS1 and α-BBS5. (H) Immunoblots of sucrose density gradient of CE of BBS3Res-A73L, BBS3Res-△N, and clip1 cells probed with α-BBS1, α-BBS5, and α-PLD. (I) Schematic presentation of how BBS3 binds and recruits the BBSome to the ciliary membrane for interacting with PLD and how PLD-associated BBSome loads onto IFT trains for ciliary exit. For panels A, B, D, and E, α-tubulin and Ac-tubulin were used to adjust the loading for WCE and CE, respectively. For panels C and F, the inset shows ciliary tips. Scale bar 10 µm.

Discussion

Using C. reinhardtii as a model organism, we elucidated the interplay between BBS3 and the BBSome for ciliary entry and investigated their dynamics in cilia and the role of BBS3 in promoting ciliary exit of the signaling protein PLD via the BBSome. Our data show that BBS3 plays a crucial role in mediating ciliary exit of PLD through promoting its association with the BBSome at the ciliary tip, thus closing a gap in our understanding of the role of BBS3 in regulating ciliary exit of signaling protein cargoes.

BBS3 and the BBSome interplay non-reciprocally for targeting to the basal body

The BBSome is the major effector of BBS3 in human cells (Jin et al., 2010). BBS3 binds the BBSome through a direct interaction with the BBSome subunit BBS1 in human, mouse, and Chlamydomonas cells (Mourão et al., 2014; Zhang et al., 2012). In the cell body of C. reinhardtii, this binding does not rely on the BBS3 nucleotide state; however, only GTP-bound BBS3 recruits the BBSome to the basal body, suggesting that basal body recruitment of the BBSome is regulated by the nucleotide state of BBS3 (Xue et al., 2020). Such a scenario would allow cells to control the amount of BBSomes available for pick-up by anterograde IFT trains at the basal body and in turn could regulate the presence and amount of signaling proteins in cilia, which rely on the BBSome for ciliary export and import via IFT (Wingfield et al., 2018; Xue et al., 2020). Indeed, basal body-associated pools have been also described for other IFT cargoes (Dai et al., 2018). Of note, the BBSome relies on GTP-bound BBS3 to target to the basal body, while GTP-bound BBS3 concentrates at the basal body even in the absence of the BBSome, suggesting that BBS3 does not rely on the BBSome for trafficking from the cell body to the basal body in C. reinhardtii. Thus, unlike the observation that GTP-bound BBS3 and the BBSome target to the ciliary base of human cells in an interdependent manner (Jin et al., 2010), the BBSome relies on GTP-bound BBS3 to target to the basal body but not vice versa in C. reinhardtii.

BBS3 and the BBSome translocate from the basal body to cilia independently

Upon targeting to the basal body, the BBSome loads onto anterograde IFT trains through associating with IFT-B1 to enter cilia (Xue et al., 2020). An analysis of both the clip1 mutant and the BBS3-knockdown strain BBS3miRNA shows that this happens even when BBS3 is not able to enter cilia. Furthermore, BBS3 translocates from the basal body to cilia even in the absence of the BBSome. These results reveal that BBS3 and the BBSome do not rely on each other for translocating from the basal body to cilia in C. reinhardtii. Loss of the N-terminal amphipathic helix essential for BBS3 to associate with the membrane prevents BBS3 from translocating from the basal body to cilia but has no effect on the ability of BBS3 to traffic from the cell body to the basal body. These results reveal that membrane association is required for BBS3 to translocate from the basal body to cilia but not for BBS3 to traffic from the cell body to the basal body. Thus, our data provide in vivo evidence, for the first time, to show that BBS3 enters cilia from the basal body potentially by lateral transport on the membrane, consistent with the notion previously proposed for rodent cells (Jin et al., 2010; Liew et al., 2014; Mourão et al., 2014; Zhang et al., 2011). Our previous study has shown that RABL5/IFT22 binds and stabilizes BBS3 independent of their nucleotide states in the cell body (Xue et al., 2020). Since the GTP-bound configuration is related to BBS3’s ability to associate with the membrane (Jin et al., 2010; Klink et al., 2020; Liew et al., 2014; Mourão et al., 2014; Singh et al., 2020; Zhang et al., 2011), IFT22 binding to BBS3 in the cell body could prevent BBS3 from associating with the cell membrane. Before ciliary entry, IFT22 is released from BBS3 at the basal body, which will enable the GTP-bound BBS3 to be in a state to attach to the membrane for lateral transport into cilia (Figure 8). Therefore, the IFT22-dependent recruitment of BBS3 to the basal body and then separation from BBS3 could also function to regulate BBS3 activity at the basal body, ensuring a spatial restriction of its association with the membrane to the basal body and ciliary compartment (Xue et al., 2020).

Figure 8
Download asset Open asset
Hypothetical model of how BBS3 enters cilia to promote ciliary exit of PLD via the BBSome in C. reinhardtii.

IFT22 and BBS3 both in a GTP-bound configuration recruit the BBSome to the basal body, where the BBSome separates from BBS3 and loads onto the anterograde IFT trains by coupling with IFT-B1 and enters cilia via IFT (Xue et al., 2020). GTP-bound IFT22 is released from BBS3 and binds IFT-B1 through a direct interaction between IFT22 and the IFT74/81 sub-complex for ciliary entry (Bhogaraju et al., 2013; Lucker et al., 2010; Taschner et al., 2014). GTP-bound BBS3 then associates with the cell membrane to diffuse into cilia. PLD enters cilia by diffusion on membrane (Liu and Lechtreck, 2018). At the ciliary tip, the BBSome is released from anterograde IFT trains through BBSome/IFT train remodeling (Xue et al., 2020). GTP-bound BBS3 binds and recruits the BBSome to the ciliary membrane for interacting with PLD (Liu and Lechtreck, 2018). PLD-laden BBSomes then load onto retrograde IFT trains by coupling with IFT-B1 for ciliary exit (Xue et al., 2020). The kinesin-II anterograde motor and the cytoplasmic dynein-1b retrograde motor are also shown (Cole et al., 1998; Pazour et al., 1998). After turnaround at the ciliary tip, kinesin-II diffuses back to the ciliary base (Chien et al., 2017; Hendel et al., 2018).

Where and how does BBS3 bind the BBSome in cilia?

Unlike its counterparts in Caenorhabditis elegans and mammalian olfactory neurons that undergo IFT in cilia (Fan et al., 2004; Williams et al., 2014), Chlamydomonas BBS3, upon entering cilia, diffuses between the ciliary base and tip (Figure 4C, D). This excludes BBS3 from coupling with BBSomes during its transportation between the ciliary base and tip, a notion also supported by the observation that partial BBS3 molecules remain to be separated from the BBSome in cilia even in its GTP-locked configuration (BBS3A73L) or in the presence of GTPγS (Figure 5A, C). However, GTP-bound BBS3 recovers BBSomes in cilia by immunoprecipitation, and a majority of GTP-locked BBS3 co-sediments with BBSomes in cilia (Figure 5A–D), revealing that GTP-bound BBS3 binds BBSomes most likely at the ciliary tip. These observations demonstrate that GTP loading does not confer BBS3 to bind BBSomes during its transportation between the ciliary base and tip. While at the ciliary tip, BBS3, however, gains the ability to bind BBSomes in a GTP-dependent manner, in agreement with the report that GTP loading confers BBS3 to bind BBSomes in cilia of human cells (Jin et al., 2010). Why GTP-locked BBS3 selects to bind or not to bind the BBSome in different ciliary compartments remains unknown at present, and the underlying molecular mechanism deserves to be further investigated (Figure 8).

BBS3 likely promotes the association of PLD with the BBSome at the ciliary tip

BBS3 is assumed to convert to and exist as a GDP-bound configuration upon entering cilia in rodent cells (Liew et al., 2014). It was also proposed that BBS3 undergoes a GTPase cycle at the ciliary tip, and RABL4/IFT27 activates GDP-bound BBS3 as a BBS3-specific GEF during this process (Liew et al., 2014). In rodent cells, GTP-bound BBS3 promotes the cargo-laden BBSome to reload onto retrograde IFT trains at the ciliary tip for ciliary exit via IFT (Liew et al., 2014). In C. reinhardtii, an analysis of the mutant strains indicates that the BBSome migrates from the basal body to cilia and cycles through cilia normally in the absence of BBS3, excluding BBS3 from mediating loading of the BBSome onto retrograde IFT trains for ciliary exit at the ciliary tip. Instead, GTP-bound BBS3 likely couples with the ciliary membrane and binds BBSomes simultaneously at the ciliary tip. This could recruit BBSomes to the ciliary membrane for interacting with PLD (Figure 8). Therefore, BBS3 is proposed to participate in mediating the association of ciliary signaling cargoes, for example, PLD, with BBSomes at the ciliary tip (Jin et al., 2010; Klink et al., 2020; Klink et al., 2017; Liew et al., 2014; Mourão et al., 2014). Interestingly, a BBS3A73L mutant can rescue the accumulated PLD to wild-type level in cilia, suggesting that, at least in cilia of Chlamydomonas cells, BBS3 that is locked in a GTP-bound configuration is able to promote ciliary signaling molecules to associate with BBSomes for ciliary exit via IFT. This eventually excludes BBS3 GTPase cycling at the ciliary tip from being involved in promoting PLD to exit cilia in C. reinhardtii (Liew et al., 2014).

Materials and methods

Key resources table
Reagent type
(species) or
resource		DesignationSource or
reference		IdentifiersAdditional
information
Genetic reagent
(C. reinhardtii)		CC-125Chlamydomonas Genetic Center (CGC)CC-125Wild-type strain
Genetic reagent
(C. reinhardtii)		CC-5325CGCCC-5325Wild-type strain
Genetic reagent
(C. reinhardtii)		clip1CGCLMJ.RY0402.149010CLiP mutant/CC-5323
Genetic reagent
(C. reinhardtii)		bbs1-1Lechtreck et al., 2009BBS1-null mutant/CC-125
Genetic reagent
(C. reinhardtii)		BBS3::YFPThis studypBKS-gBBS3::YFP-Paro/CC-125
Genetic reagent
(C. reinhardtii)		BBS3A73L::YFPThis studypBKS-gBBS3A73L::YFP-Paro/CC-125
Genetic reagent
(C. reinhardtii)		BBS5::YFPXue et al., 2020pBKS-gBBS5::YFP-Paro/CC-125
Genetic reagent
(C. reinhardtii)		BBS3::YFP5325This studypBKS-gBBS3::YFP-Ble/CC-5325
Genetic reagent
(C. reinhardtii)		BBS3::YFPclip1This studypBKS-gBBS3::YFP-Ble/clip1
Genetic reagent
(C. reinhardtii)		BBS5::YFP5325Xue et al., 2020pBKS-gBBS5::YFP-Ble/CC-5325
Genetic reagent
(C. reinhardtii)		BBS5::YFPclip1This studypBKS-gBBS5::YFP-Ble/clip1
Genetic reagent
(C. reinhardtii)		BBS3::YFP1-1This studypBKS-gBBS3::YFP-Ble/bbs1-1
Genetic reagent
(C. reinhardtii)		BBS3△N::YFP1-1This studypBKS-gBBS3△N::YFP-Ble/bbs1-1
Genetic reagent
(C. reinhardtii)		BBS3△N::YFPThis studypBKS-gBBS3△N::YFP-Ble/CC-125
Genetic reagent
(C. reinhardtii)		BBS3miRNAXue et al., 2020pMI-BBS3-Paro/CC-125
Genetic reagent
(C. reinhardtii)		BBS3Res-WTXue et al., 2020pBKS-gBBS3::GFP-Ble/BBS3miRNA
Genetic reagent
(C. reinhardtii)		BBS3Res-A73LXue et al., 2020pBKS-gBBS3A73L::GFP-Ble/BBS3miRNA
Genetic reagent
(C. reinhardtii)		IFT25miRNADong et al., 2017bpMI-IFT25-Paro/CC-125
Genetic reagent
(C. reinhardtii)		BBS3Res-△NThis studypBKS-gBBS3△N::YFP-Ble/BBS3miNRA
Genetic reagent
(C. reinhardtii)		HR-YFPThis studypBKS-HSP
70A-RBCS
2-YFP-Ble/CC-125
AntibodyAnti-IFT46
(rabbit polyclonal)		Dong et al., 2017bimmunoblotting (1:1,000)
AntibodyAnti-IFT57
(rabbit polyclonal)		Dong et al., 2017bimmunoblotting (1:1,000)
AntibodyAnti-IFT70
(rabbit polyclonal)		Dong et al., 2017bimmunoblotting (1:1,000)
AntibodyAnti-BBS1
(rabbit polyclonal)		Xue et al., 2020immunoblotting (1:1,000) immunofluorescence (1:200)
AntibodyAnti-BBS3
(rabbit polyclonal)		Xue et al., 2020immunoblotting (1:500) immunofluorescence (1:200)
AntibodyAnti-BBS4
(rabbit polyclonal)		This studyimmunoblotting (1:500)
AntibodyAnti-BBS5
(rabbit polyclonal)		Xue et al., 2020immunoblotting (1:1000) immunofluorescence (1:200)
AntibodyAnti-BBS7
(rabbit polyclonal)		This studyimmunoblotting (1:1000)
AntibodyAnti-PLD
(rabbit polyclonal)		This studyimmunoblotting (1:1000)
AntibodyAnti-α-tubulin
(mouse monoclonal)		Sigma-AldrichB512immunoblotting (1:25,000)
AntibodyAnti-Ac-tubulin
(mouse monoclonal)		Sigma-Aldrich6-11B-1immunoblotting (1:50,000)
AntibodyAnti-GFP (YFP)
(mouse monoclonal)		Roche7.1 and 13.1immunoblotting (1:1,000)
AntibodyHRP-conjugated goat anti-mouse IgGJackson Lab.RRID:AB_10015289immunoblotting (1:10,000)
AntibodyHRP-conjugated goat anti-rabbit IgGJackson Lab.RRID:AB_2313567immunoblotting (1:10,000)
AntibodyAlexa-Fluor 594-conjugated goat anti-rabbit IgGMolecular ProbesRRID:AB_142057immunofluorescence (1:400)
AntibodyAlexa-Flour 488-conjugated goat anti-mouse IgGMolecular ProbesRRID:AB_2536097immunofluorescence (1:400)

Chlamydomonas strains and culture conditions

Request a detailed protocol

Chlamydomonas strains including CC-125, CC-5325, and the CLiP mutant (LMJ.RY0402.149010) were purchased from the Chlamydomonas Genetic Center at the University of Minnesota, Twin Cities, MN (http://www.chlamy.org). BBS1-null mutant bbs1-1, BBS3-knockdown strain BBS3miRNA, BBS3-rescuing strains BBS3Res-WT and BBS3Res-A73L, IFT25-knockdown strain IFT25miRNA, BBS5::YFP-expressing strains BBS5::YFP5325 and BBS5::YFP have been reported previously (Dong et al., 2017b; Lechtreck et al., 2009; Xue et al., 2020). All strains were listed in the key resources table. Strains were grown in Tris acetic acid phosphate (TAP) medium under continuous light with constant aeration at room temperature. Depending on a specific strain, cells were cultured with or without the addition of 20 µg/ml paromomycin (Sigma-Aldrich), 15 µg/ml bleomycin (Invitrogen), or both antibiotics with 10 µg/ml paromomycin and 5 µg/ml bleomycin.

Vectors and transgenic strain generation

Request a detailed protocol

To express BBS3::YFP, YFP was amplified from pHK214 (Lv et al., 2017) by using the primer pair GFP-FOR1 (5'-CGGAATTCATGGCCAAGGGCGAGG-3') and GFP-REV (5'-CCGCTCGAGTTACTTGTACAGCTCGTCCATGC-3') with EcoRI and XhoI restriction enzyme sites located in its 5'- and 3'-end, respectively, and inserted into EcoRI and XhoI sites of pBKS-gBBS3::GFP-Ble (Xue et al., 2020), resulting in pBKS-gBBS3::YFP-Ble. To express BBS3A73L::YFP, the BBS3A73L DNA fragment was cut from pBKS-gBBS3A73L::GFP-Paro (Xue et al., 2020) and inserted into the XbaI and EcoRI sites of pBKS-gBBS3::YFP-Ble, resulting in pBKS-gBBS3A73L::YFP-Ble. To express BBS3△N::YFP, the BBS3 promoter and BBS3△N fragment was amplified from pBKS-gBBS3::YFP-Ble using the primer pair gBBS3-FOR1 (5'-GCTCTAGATTCCCACTCCCGCAGCC-3') and gBBS3-REV1 (5'-GAACAGCCACAACATGCTCTTGTCGCTGTTTGG-3') and gBBS3-FOR2 (5'-CCAAACAGCGACAAGAGCATGTTGCTGGCTGTTC-3') and gBBS3-REV2 (5'-GGAATTCGCTGAGGCGCTCCGCC-3'), respectively. The two fragments were inserted into the XbaI and EcoRI sites of pBKS-gBBS3::YFP-Ble by three-way ligation, resulting in pBKS-gBBS3△N::YFP-Ble. The BBS5::YFP-expressing vectors pBKS-gBBS5::YFP-Paro and pBKS-gBBS5::YFP-Ble have been described previously (Xue et al., 2020). To express YFP, YFP sequence was cut from pBKS-gBBS5::YFP-Ble and inserted into the EcoRI and XhoI sites of pBKS-HSP70A-RBCS2-GFP-Ble for replacing the GFP segment, resulting in pBKS-HSP70A-RBCS2-YFP-Ble (Dong et al., 2017a). After verification by direct nucleotide sequencing, the new constructs were transformed into Chlamydomonas strain by electroporation as described previously, and screening of positive transformants was done according to the method described previously (Xue et al., 2020).

DNA and mRNA analysis

Request a detailed protocol

Chlamydomonas genomic DNA was extracted and purified according to our protocol reported previously (Dong et al., 2017b). To amplify BBS3 genomic sequence, 20 ng of genomic DNA was used as template and the PCR reaction was performed at 95°C for 2 min followed by 30 cycles of 95°C for 10 s, 61°C for 30 s, and 72°C for 4 min with the primer pair gBBS3-FOR (5'-GCTCTAGATTCCCACTCCCGCAGCC-3') and gBBS3-REV (5'-GGAATTCGCTGAGGCGCTCCGCC-3'). For BBS3 mRNA analysis, total RNA was extracted according to our previously reported protocol (Dong et al., 2017b). Five micrograms of mRNA was reverse-transcribed at 42°C for 1 hr with M-MLV Reverse Transcriptase (Promega) and 3'-RACE Oligo (dT) primer (5'-GCCTAGCGTCGTTCCAGCAGTGATTTACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT-3'). PCR was performed to amplify BBS3 cDNA with primer pair cBBS3-FOR (5'-CCGGATCCATGGGCTTCTTTGACAAG-3') and cBBS3-REV (5'-CCGAATTCGCTGAGGCGCTCCGCCAG-3'). 3'-RACE-PCR was performed to determine the exact 3'-end nucleotide sequence of BBS3 cDNA with the primer pair cBBS3-FOR1 (5'-CCGAATTCTGGCAATGCCACCCGTGGAAATCGCC-3') and cBBS3-3'-RACE-REV (5'-CCCTCGAGTAGCGTCGTTCCAGCAGTGATTTAC-3'). PCRs were performed at 95°C for 30 s followed by 30 cycles of 95°C for 30 s, 57°C for 30 s, and 72°C for 1 min. The amplified PCR products were then visualized in agarose gel and purified for nucleotide sequencing.

Antibodies and immunoblotting

Request a detailed protocol

Polyclonal antibodies raised in rabbits have been described previously (Dong et al., 2017b; Xue et al., 2020; Zhu et al., 2017). Rabbit-originated antibodies against BBS4, BBS7, and PLD were generated by Beijing Protein Innovation. Monoclonal antibodies against GFP (YFP) (mAbs 7.1 and 13.1, Roche), α-tubulin (mAb B512, Sigma), and Ac-tubulin (mAb 6-11B-1, Sigma-Aldrich) were commercially purchased (key resources table). Preparation of whole cell, cell body, and ciliary extracts, SDS-PAGE electrophoresis, and immunoblotting were done as detailed previously (Xue et al., 2020). If not otherwise specified, 20 µg of total protein from each sample was loaded for SDS-PAGE. In immunoblotting assays, dilution used for primary and secondary antibodies is listed in the key resources table.

Isolation of cilia and cell bodies

Request a detailed protocol

Methods for the isolation of cilia and cell bodies have been described previously (Xue et al., 2020). Briefly, cells were suspended in 150 mL of TAP (pH 7.4) and incubated for 2~4 hr under strong light with bubbling. Then, 0.5 M acetic acid was added to reach a pH value of 4.5 to deciliate cells before 0.5 M KOH was added to reach a pH value of 7.4. After centrifugation (600 ×g at 4°C for 5 min), cell bodies (pellets) and cilia (supernatants) were collected separately. Cilia were then repeatedly washed with HMDEK (10 mM Hepes, pH 7.4, 5 mM MgSO4, 1 mM dithiothreitol [DTT], 5 mM EDTA, and 25 mM KCl) by centrifugation (14,000 ×g at 4°C for 10 min) until the green color disappeared completely.

Preparation of ciliary fractions

Request a detailed protocol

After cilia were isolated, they were dissolved in HMDEK buffer (50 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM DTT, 0.5 mM EDTA, and 25 mM KCl) plus protein inhibitors (PI) (1 mM PMSF, 50 μg/ml soybean trypsin inhibitor, 1 μg/ml pepstatin A, 2 μg/ml aprotinin, and 1 μg/ml leupeptin) and fresh-frozen in liquid nitrogen. The ciliary matrix fraction was obtained by freezing and thawing cilia followed by centrifugation (27,000 ×g, 4°C, 15 min), and the pellets were dissolved in an HMEDK buffer containing 0.5% NP-40 and stayed on ice for 15 min. The supernatant and pellet were collected after centrifugation (14,000 ×g at 4°C for 10 min) as membrane and axonemal fractions, respectively, according to a previously described method (Liang et al., 2014).

Preparation of liposome and binding assays

Request a detailed protocol

Liposomes were prepared exactly as described previously (Jin et al., 2010). BBS3 association with liposome was conducted in an HMEK buffer. Liposomes (2 µg) were incubated with 100 µg of bacterially expressed C-terminal 6×His tagged BBS3::YFP or BBS3△N::YFP in the presence of GTPγS (100 mM), GDP (100 mM), or neither in a 100 µL reaction at 30°C for 1 hr. The reactions were centrifuged at 385,000 ×g for 30 min at 24°C, and equal portions of the resulting pellets were resolved by SDS-PAGE and immunoblotted with α-BBS3.

Immunoprecipitation

Request a detailed protocol

Cell bodies and cilia isolated from Chlamydomonas strains expressing YFP-tagged BBS3 or its variants were resuspended in HMEK+PI supplemented with 50 mM NaCl and lysed by adding nonidet P-40 (NP-40) to 1%. The supernatants were collected by centrifugation (14,000 ×g, 4°C, 10 min) and incubated with agitation with 5% BSA-pretreated camel anti-GFP antibody-conjugated agarose beads (V-nanoab Biotechnology) for 2 hr at 4°C. The beads were then washed with HMEK containing 150 mM NaCl, 50 mM NaCl, and finally 0 mM NaCl. The beads were then added with Laemmli SDS sample buffer and boiled for 5 min before centrifuging at 2,500 ×g for 5 min. The supernatants were then analyzed by immunoblotting as described above.

Immunofluorescence

Request a detailed protocol

Immunofluorescence staining was performed according to our published method (Fan et al., 2010). The primary antibodies against PLD, YFP, BBS3, BBS1, and BBS5 and the secondary antibodies – Alexa-Fluor594-conjugated goat anti-rabbit IgG and Alexa-Fluor488-conjugated goat anti-mouse IgG (Molecular Probes, Eugene, OR) – are listed in the key resources table with their suggested dilutions for immunofluorescence staining. Images were captured with an IX83 inverted fluorescent microscope (Olympus) equipped with a back illuminated scientific CMOS camera (Prime 95B, Photometrics) at 100× amplification and processed with CellSens Dimension (version 2.1, Olympus).

Sucrose density gradient centrifugation

Request a detailed protocol

Sucrose density gradient centrifugation of ciliary extracts was performed according to our published method (Wang et al., 2009). In brief, linear 12 mL of 10–25% sucrose density gradients in 1× HMDEK buffer plus protease inhibitors and 1% NP-40 were generated using the Jule Gradient Former (Jule Inc, Milford, CT) and used within 1 hr. The cilia were opened with liquid nitrogen for three rounds of frozen-and-thaw cycles and centrifuged at 12,000 rpm, 4°C, for 10 min. Seven hundred microliters of ciliary extracts were then loaded on the top of the gradients and separated at 38,000 rpm, 4°C, for 14 hr in a SW41Ti rotor (Beckman Coulter). The gradients were fractioned into 24–26 0.5 ml aliquots using a Pharmacia LKB Pump P-1 coupled with a FRAC-100 fraction collector. The standards used to calculate S-values were BSA (4.4S), aldolase (7.35S), catalase (11.3S), and thyroglobulin (19.4S). Twenty microliters of each fraction was analyzed by immunoblotting as described above. If necessary, the assay was carried out in the presence of GTPγS (20 mM) or GDP (20 mM), respectively.

IFT video imaging and speed measurements

Request a detailed protocol

The motility of GFP- and YFP-tagged proteins in cilia was imaged at ~15 fps using TIRF microscopy on an inverted microscope (IX83, Olympus) equipped with a through-the-objective TIRF system, a 100×/1.49 NA TIRF oil immersion objective (Olympus), and a back-illuminated scientific CMOS camera (Prime 95B, Photometrics) as detailed previously (Xue et al., 2020). To quantify IFT speeds and frequencies, kymograms were generated and measured with CellSens Dimension (version 2.1, Olympus).

Protein expression and purification

Request a detailed protocol

The cDNAs encoding BBS3, BBS3A73L, and BBS3T31R were amplified from pGEX-6P-cBBS3, pGEX-6P-cBBS3A73L, and pGEX-6P-cBBS3T31R using the primer pair cBBS3-FOR and cBBS3-REV as described earlier. The cDNAs of BBS3 and its mutants were inserted into the BamHI and Hind III sites of pET-28a (Novagen) to result in pET-28a-cBBS3, pET-28a-cBBS3A73L, and pET-28a-cBBS3T31R, respectively. To express YFP, the cDNA of YFP was cut from pBKS-gBBS3::YFP-Ble with EcoRI and XhoI and inserted into pET-28a (Novagen) to result in pET-28a-YFP. To express the C-terminal YFP-tagged BBS3 and BBS3ΔN, the cDNAs of BBS3 and BBS3ΔN were amplified from pGEX-6P-cBBS3 using the primer pair cBBS3-FOR and cBBS3-REV (for BBS3) and cBBS3ΔN-FOR (5'-CCGGATCCATGCTCTTGTCGCTG-3') and cBBS3-REV (for BBS3ΔN) and inserted into BamHI and EcoRI sites of pET-28a-YFP to result in pET-28a-BBS3::YFP and pET-28a-BBS3ΔN::YFP. After these plasmids were transformed into bacteria, the bacterially expressed recombinant proteins were purified with Ni-NTA beads and cleaved with thrombin (Solarbio) to get rid of the N-terminal 6× His tag according to our previous report (Xue et al., 2020). If necessary, 10 μg of proteins from elutes was resolved on 12% SDS-PAGE gels and visualized with Coomassie Blue staining.

Small GTPase assay

Request a detailed protocol

Small GTPase assay was performed according to our previous report (Xue et al., 2020). Intrinsic GTP hydrolysis of the bacterially expressed BBS3, BBS3A73L, and BBS3T31R was measured by optical assay for the release of inorganic phosphate with reagents from the QuantiChrom ATPase/GTPase assay kit (Bioassay Systems) (Pan et al., 2006).

Statistical analysis

Request a detailed protocol

Statistical analysis was performed with GraphPad Prism 8.0 (GraphPad Software). For comparisons on speeds and frequencies of the GFP- and YFP-labeled proteins, one-sample unpaired Student's t-test was used. Data were presented as mean ± SD from three independently performed experiments, and n means sample numbers. n.s. represents non-significance. If not mentioned elsewhere, significance was set as p<0.05.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

References

Decision letter

  1. Junmin Pan
    Reviewing Editor; Tsinghua University, China
  2. Anna Akhmanova
    Senior Editor; Utrecht University, Netherlands

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

This manuscript is of broad interest to scientists in the field of ciliary biology. The identification of BBS3 for entry into cilia separately from BBsome and its role in mediating membrane protein exit from cilia have deepened our understanding of the mechanism of ciliary exit of membrane proteins.

Decision letter after peer review:

Thank you for submitting your article "Bardet-Biedl Syndrome 3 Protein Mediates Phototaxis through Promoting Ciliary Exit of Phospholipase D via the BBSome" for consideration by eLife. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is "in revision at eLife". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

Summary:

BBSome is critical for membrane protein trafficking within cilia. The current work demonstrates that BBS3 enters and exits cilia separately from BBsome, and functions at the ciliary tip to load membrane proteins for their exit, which are unique findings. However, several major concerns were raised about the data to support the model proposed in the manuscript. We would like the authors to consider the points listed below should a revision be prepared.

Essential revisions:

1) This manuscript proposed that GTP form is required for ciliary entry of BBS3 and for loading PLD at the ciliary tip. However, no direct in vivo data were shown to support this. Expressing a GTP form in the BBS3 RNAi strain or other BBS3 null mutants, is needed to show how the GTP form behaves (such as, where it localizes in the cilia, how it moves along the cilia) in cilia and if PLD accumulates at the ciliary tip.

2) The claim that ciliary entry of BBS3 does not require BBSome was demonstrated in a bbs-1 null mutant. However, in Figure 3C, it showed that BBS1 is still present in the cell extracts of bbs-1 mutant. Thus this claim is not supported by the data though in Figure 2A it showed BBS1 was not present in the mutant. New experiments should be performed to clarify this.

3) Some critical data are derived from using the clip1 mutant. However, the authors claimed that the clip1 strain must contain other unidentified mutation(s) because an apparently wild-type BBS3 protein is expressed. Since the nature of this "other unidentified mutation(s)" is unclear, it raises serious concerns about the conclusions made using the clip1 mutant. Therefore, it is requested to look more carefully at the BBS3 mutation in the clip1 mutant. Given the limited information the authors supply in the manuscript, it is still possible that the BBS3 protein detected in the clip1 mutant is slightly truncated/modified at the C-terminus. If BBS3 expressed in clip1 is modified at the C-terminus, this indicates that the C-terminus in addition to its N-terminus is critical for its transport into flagella and lack of C-terminus is dominant negative. The experiments needed is to look at the full-length BBS3 cDNA (a 3' end RACE might suffice). If cDNA sequence shows that a modified BBS3 protein is expressed in the clip1 mutant, we request to confirm that the BBSome phenotype in this clip1 mutant is caused by this mutation by expressing this form of BBS3 protein in a BBS3 RNAi strain or a BBS3 null strain. And the conclusions obtained using the clip1 mutant in this manuscript is legitimate. If cDNA sequence shows that a wild-type BBS3 protein is expressed in clip1 mutant, we request to confirm any conclusions obtained using the clip1 mutant with a cell line that has the same phenotype but the mutation background is clear (a good candidate would be a BBS3RNAi strain that expresses BBS3ΔN).

4) BBS3ΔN expressed to a level barely exceeding that of the remaining endogenous BBS3 (Figure 7D) was able to rescue the flagellar levels of BBSome components to an extent that appears to exceed those in the wild-type flagella (Figure 7E). It could mean that BBSome was accumulated in the cilia due to lack of retrograde transport, thus arguing against the claim of a BBS3-independent IFT of BBSome (Figure 6H) based solely on the weird clip1 strain. Therefore, a critical experiment would be to examine flagellar BBSome trafficking in this strain or preferably in a rescue strain expressing a higher level (e.g. at least similar to the wild-type level) of BBS3ΔN.

5) Figure 1F: IP lacks negative control. Lysate from a strain expressing YFP alone or an irrelevant YFP-fusion protein should be used as negative control.

6) Figure 3B: I suggest the authors show either the input or the quality of the bacterially-expressed proteins.

7) Demonstrate a BBS3-GTP-dependent association of PLD with BBSome in fractionation experiments like those in Figure 5A and C.

8) An interesting finding of this paper is that BBS3 doesn't undergo IFT within cilia. However, this conclusion was drawn based on the TIRF results using cell lines with wild-type BBS3 background. It is requested to check tagged BBS3 movement in a BBS3-null background or in a BBS3 RNAi strain (The BBS3res-WT strain in Xue et al., 2020, might be a good candidate).

https://doi.org/10.7554/eLife.59119.sa1

Author response

Essential revisions:

1) This manuscript proposed that GTP form is required for ciliary entry of BBS3 and for loading PLD at the ciliary tip. However, no direct in vivo data were shown to support this. Expressing a GTP form in the BBS3 RNAi strain or other BBS3 null mutants, is needed to show how the GTP form behaves (such as, where it localizes in the cilia, how it moves along the cilia) in cilia and if PLD accumulates at the ciliary tip.

Our previous study has shown that GTP- but not GDP-bound BBS3 enters cilia (Xue et al., 2020). In the current study, we actually have provided in vivo evidence by using both the clip1 mutant and the BBS3-knockdown strain BBS3miRNA to show that BBS3 promotes PLD loading onto the BBSome at the ciliary tip for ciliary exit (Figure 7). In addition, we have performed ciliary fraction assays to show that the GTP-bound mutant BBS3A73L::YFP localizes in the ciliary membrane (Figure 4E and F). In our revised manuscript, we have performed TIRF analysis, as requested, to determine movement of BBS3A73L::YFP in the BBS3-knockdown strain BBS3miRNA (Figure 4D). Similar to BBS3A73L::YFP expressed in wild-type CC-125 cells (Figure 4A-C), BBS3A73L::YFP undergoes diffusion in cilia of BBS3miRNA cells (Figure 4D). We also have found that BBS3A73L::YFP restored the accumulated PLD to wild-type level in cilia of BBS3miRNA cells, revealing that GTPase cycling of BBS3 is not required for PLD turnaround at the ciliary tip for ciliary exit (Figure 7D and E). Please see our revised manuscript for details.

2) The claim that ciliary entry of BBS3 does not require BBSome was demonstrated in a bbs-1 null mutant. However, in Figure 3C, it showed that BBS1 is still present in the cell extracts of bbs-1 mutant. Thus this claim is not supported by the data though in Figure 2A it showed BBS1 was not present in the mutant. New experiments should be performed to clarify this.

We have accidently combined a wrong band of BBS1 into Figure 3C. In the revised manuscript, we have performed western blotting assay again to assure that the bbs1-1 mutant is indeed a BBS1-null mutant and have integrated the correct band into Figure 3C. Please see our revised Figure 3C for details.

3) Some critical data are derived from using the clip1 mutant. However, the authors claimed that the clip1 strain must contain other unidentified mutation(s) because an apparently wild-type BBS3 protein is expressed. Since the nature of this "other unidentified mutation(s)" is unclear, it raises serious concerns about the conclusions made using the clip1 mutant. Therefore, it is requested to look more carefully at the BBS3 mutation in the clip1 mutant. Given the limited information the authors supply in the manuscript, it is still possible that the BBS3 protein detected in the clip1 mutant is slightly truncated/modified at the C-terminus. If BBS3 expressed in clip1 is modified at the C-terminus, this indicates that the C-terminus in addition to its N-terminus is critical for its transport into flagella and lack of C-terminus is dominant negative. The experiments needed is to look at the full-length BBS3 cDNA (a 3' end RACE might suffice). If cDNA sequence shows that a modified BBS3 protein is expressed in the clip1 mutant, we request to confirm that the BBSome phenotype in this clip1 mutant is caused by this mutation by expressing this form of BBS3 protein in a BBS3 RNAi strain or a BBS3 null strain. And the conclusions obtained using the clip1 mutant in this manuscript is legitimate. If cDNA sequence shows that a wild-type BBS3 protein is expressed in clip1 mutant, we request to confirm any conclusions obtained using the clip1 mutant with a cell line that has the same phenotype but the mutation background is clear (a good candidate would be a BBS3RNAi strain that expresses BBS3ΔN).

Similar to the observation that the endogenous BBS3 only enriches at the basal bodies but is not able to enter cilia in clip1 mutant cells (Figure 1B and E), a C-terminal YFP-tagged BBS3 (BBS3::YFP) also targets to the basal bodies but cannot enter cilia in BBS3::YFPclip1 cells, confirming that wild-type BBS3 itself loses its ability for ciliary entry in the clip1 mutant (Figure 1D). As requested, we performed 3'-end RACE analysis to determine the exact 3'-end sequence of BBS3 mRNA in clip1 mutant and found that clip1 mutant contains wild-type BBS3 mRNA, revealing that BBS3 itself remains intact in clip1 mutant but loses its ability to enter cilia (please see Figure 1—figure supplement 1F and G). In our original manuscript, we have confirmed this observation by expressing BBS3△N::YFP in the BBS3-knockdown strain BBS3miRNA (Figure 7D and E). Our data showed that BBS3△N::YFP binds and targets the BBSome to the basal bodies but does not enter cilia itself. By such a way, BBS3△N::YFP rescues the BBSome to wild-type level in cilia, confirming that the absence of BBS3 in cilia does not affect ciliary content of the BBSome. In the revised section entitled “BBS3 is not required for the BBSome to enter cilia from the basal body”, we accordingly deleted the sentence “we propose that the clip1 strain must contain other unidentified mutation(s)” and replaced “To verify this observation” with “To verify that BBS3 is not able to enter cilia in clip1 cells” and added one sentence of “This notion was confirmed when BBS3 knockdown and rescue studies were performed (Figure 7D and E)”.

In the revised section entitled “BBS3 is essential for PLD to associate with the BBSome for ciliary exit”, we emphasized this by rewriting sentences as “When BBS3::GFP was expressed in BBS3miRNA cells (resulting the strain BBS3Res-WT) it entered cilia and restored BBS1, BBS5 and PLD to wild-type levels (Figure 7D-F) (Xue et al., 2020). […] In addition, BBS3△N::YFP did not enter cilia itself but restored BBS1 and BBS5 to wild-type levels in cilia of the BBS3-knockdown BBS3miRNA cells (Figure 7D-F), providing compelling evidence to confirm that ciliary entry of the BBSome from the ciliary base does not depend on BBS3 (Figure 1).”

4) BBS3ΔN expressed to a level barely exceeding that of the remaining endogenous BBS3 (Figure 7D) was able to rescue the flagellar levels of BBSome components to an extent that appears to exceed those in the wild-type flagella (Figure 7E). It could mean that BBSome was accumulated in the cilia due to lack of retrograde transport, thus arguing against the claim of a BBS3-independent IFT of BBSome (Figure 6H) based solely on the weird clip1 strain. Therefore, a critical experiment would be to examine flagellar BBSome trafficking in this strain or preferably in a rescue strain expressing a higher level (e.g. at least similar to the wild-type level) of BBS3ΔN.

As requested, we have carefully conducted the assay again and found that the selected rescue strain expresses BBS3△N::YFP and endogenous BBS3 to a combined amount equivalent to BBS3 alone in CC-125 cells. Similar to the clip1 mutant in which ciliary content of the BBSome is not affected by BBS3, BBS3△N::YFP rescues the BBSome components to wild-type levels in cilia of the BBS3-knockdown BBS3miRNA cells, revealing that ciliary presence of BBS3 is not required for maintaining BBSome content at wild-type level in cilia (Figure 7D and E). Please see our revised Figure 7D and E for details.

5) Figure 1F: IP lacks negative control. Lysate from a strain expressing YFP alone or an irrelevant YFP-fusion protein should be used as negative control.

As requested, we have expressed YFP alone in CC-125 cells and added lysate from this YFP-expressing strain as a negative control in Figure 1F in our revised manuscript. Please see our revised Figure 1F for details.

6) Figure 3B: I suggest the authors show either the input or the quality of the bacterially-expressed proteins.

As suggested, we have added the Coomassie staining of SDS-PAGE of the purified BBS3::YFP and BBS3△N::YFP to show the input and quality of the bacterially-expressed proteins in Figure 3B. Please see our revised Figure 3B for details.

7) Demonstrate a BBS3-GTP-dependent association of PLD with BBSome in fractionation experiments like those in Figure 5A and C.

As requested, we have performed immunoblotting assays to determine the BBS3-GTP-dependent association of PLD with the BBSome in sucrose density gradient centrifugation. As shown in Figure 7H, PLD rarely co-sediments with the BBSome components BBS1 and BBS5 in ciliary extracts of clip1 cells but primarily co-fractions with the BBSome in ciliary extracts of BBS3Res-A73L but not BBS3Res-△N cells. We emphasized this in the revised section entitled “BBS3 is essential for PLD to associate with the BBSome for ciliary exit” by adding sentences as “Together with the observation that PLD rarely co-sedimented with the BBSome (checked with BBS1 and BBS5) in ciliary extracts of clip1 cells; a minority of PLD co-sedimented with the BBSome in ciliary extracts of BBS3Res-△N cells; and the majority of PLD became co-sedimented with the BBSome in ciliary extracts of BBS3Res-A73L cells (Figure 7H), our data suggest that GTP-bound BBS3 efficiently enables PLD to associate with the BBSome in cilia at the ciliary tip to undergo retrograde IFT (Figure 7I).”

8) An interesting finding of this paper is that BBS3 doesn't undergo IFT within cilia. However, this conclusion was drawn based on the TIRF results using cell lines with wild-type BBS3 background. It is requested to check tagged BBS3 movement in a BBS3-null background or in a BBS3 RNAi strain (The BBS3res-WT strain in Xue et al., 2020, might be a good candidate).

As requested, we have performed TIRF analysis on BBS3Res-WT and BBS3Res-A73L cells (please see Figure 4D; and Figure 4—video3 and 4). BBS3::GFP and BBS3A73L::GFP both showed a pattern of diffusion but not IFT in cilia of BBS3Res-WT and BBS3Res-A73L cells. We described this in the section entitled “BBS3 associates with the ciliary membrane in a GTP-dependent manner” as “Similar stationary pattern was also recorded for the C-terminal green fluorescent protein (GFP)-tagged BBS3 and the A73L mutant in the rescuing strains BBS3Res-WT and BBS3Res-A73L, in which BBS3::GFP and BBS3A73L::GFP are expressed in similar amounts in the BBS3-knockdown strain BBS3miRNA (Figure 4D; and Figure 4—videos 3 and 4) (Xue et al., 2020)”. Please see our revised manuscript for details.

https://doi.org/10.7554/eLife.59119.sa2

Article and author information

Author details

  1. Yan-Xia Liu

    State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, Tianjin, China
    Contribution
    Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Project administration
    Contributed equally with
    Bin Xue
    Competing interests
    No competing interests declared

  2. Bin Xue

    State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, Tianjin, China
    Contribution
    Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology
    Contributed equally with
    Yan-Xia Liu
    Competing interests
    No competing interests declared

  3. Wei-Yue Sun

    State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, Tianjin, China
    Contribution
    Investigation, Methodology
    Competing interests
    No competing interests declared

  4. Jenna L Wingfield

    Department of Cellular Biology, University of Georgia, Athens, United States
    Contribution
    Investigation, Writing - review and editing
    Competing interests
    No competing interests declared

  5. Jun Sun

    State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, Tianjin, China
    Contribution
    Resources, Funding acquisition
    Competing interests
    No competing interests declared

  6. Mingfu Wu

    Department of Molecular and Cellular Physiology, Albany Medical College, Albany, United States
    Contribution
    Formal analysis
    Competing interests
    No competing interests declared

  7. Karl F Lechtreck

    Department of Cellular Biology, University of Georgia, Athens, United States
    Contribution
    Funding acquisition, Investigation
    Competing interests
    No competing interests declared

  8. Zhenlong Wu

    State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China
    Contribution
    Formal analysis
    Competing interests
    No competing interests declared

  9. Zhen-Chuan Fan

    State Key Laboratory of Food Nutrition and Safety, Institute of Health Biotechnology, Tianjin University of Science and Technology, Tianjin, China
    Contribution
    Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Validation, Writing - original draft, Project administration, Writing - review and editing
    For correspondence
    fanzhen@tust.edu.cn
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1712-3413

Funding

National Natural Science Foundation of China (32070698)

  • Zhen-Chuan Fan

Tianjin Municipal Science and Technology Commission (18JCZDJC34100)

  • Zhen-Chuan Fan

Tianjin Municipal Science and Technology Commission (19PTSYJC00050)

  • Zhen-Chuan Fan

International Center for Genetic Engineering and Biotechnology (CRP/CHN15-01)

  • Zhen-Chuan Fan

National Natural Science Foundation of China (41876134)

  • Jun Sun

National Institutes of Health (GM110413)

  • Karl F Lechtreck

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by National Natural Science Foundation of China grant 32070698, Tianjin Municipal Science and Technology Bureau grants 19PTSYJC00050 and 18JCZDJC34100, and International Center for Genetic Engineering and Biotechnology grant CRP/CHN15-01 (ZCF), National Natural Science Foundation of China grant 41876134 (JS), and the National Institutes of Health grant GM110413 (KFL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Senior Editor

  1. Anna Akhmanova, Utrecht University, Netherlands

Reviewing Editor

  1. Junmin Pan, Tsinghua University, China

Publication history

  1. Received: May 20, 2020
  2. Accepted: February 13, 2021
  3. Accepted Manuscript published: February 15, 2021 (version 1)
  4. Version of Record published: March 16, 2021 (version 2)

Copyright

© 2021, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,085
    Page views
  • 166
    Downloads
  • 6
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    The mitotic spindle protein CKAP2 potently increases formation and stability of microtubules

    Thomas S McAlear, Susanne Bechstedt
    Research Article Updated

    Cells increase microtubule dynamics to make large rearrangements to their microtubule cytoskeleton during cell division. Changes in microtubule dynamics are essential for the formation and function of the mitotic spindle, and misregulation can lead to aneuploidy and cancer. Using in vitro reconstitution assays we show that the mitotic spindle protein Cytoskeleton-Associated Protein 2 (CKAP2) has a strong effect on nucleation of microtubules by lowering the critical tubulin concentration 100-fold. CKAP2 increases the apparent rate constant ka of microtubule growth by 50-fold and increases microtubule growth rates. In addition, CKAP2 strongly suppresses catastrophes. Our results identify CKAP2 as the most potent microtubule growth factor to date. These finding help explain CKAP2’s role as an important spindle protein, proliferation marker, and oncogene.

    1. Cell Biology
    2. Physics of Living Systems

    Volume growth in animal cells is cell cycle dependent and shows additive fluctuations

    Clotilde Cadart et al.
    Research Article

    The way proliferating animal cells coordinate the growth of their mass, volume, and other relevant size parameters is a long-standing question in biology. Studies focusing on cell mass have identified patterns of mass growth as a function of time and cell cycle phase, but little is known about volume growth. To address this question, we improved our fluorescence exclusion method of volume measurement (FXm) and obtained 1700 single-cell volume growth trajectories of HeLa cells. We find that, during most of the cell cycle, volume growth is close to exponential and proceeds at a higher rate in S-G2 than in G1. Comparing the data with a mathematical model, we establish that the cell-to-cell variability in volume growth arises from constant-amplitude fluctuations in volume steps rather than fluctuations of the underlying specific growth rate. We hypothesize that such ‘additive noise’ could emerge from the processes that regulate volume adaptation to biophysical cues, such as tension or osmotic pressure.

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics

    SSNA1 stabilizes dynamic microtubules and detects microtubule damage

    Elizabeth J Lawrence et al.
    Research Article Updated

    Sjögren’s syndrome nuclear autoantigen-1 (SSNA1/NA14) is a microtubule-associated protein with important functions in cilia, dividing cells, and developing neurons. However, the direct effects of SSNA1 on microtubules are not known. We employed in vitro reconstitution with purified proteins and TIRF microscopy to investigate the activity of human SSNA1 on dynamic microtubule ends and lattices. Our results show that SSNA1 modulates all parameters of microtubule dynamic instability—slowing down the rates of growth, shrinkage, and catastrophe, and promoting rescue. We find that SSNA1 forms stretches along growing microtubule ends and binds cooperatively to the microtubule lattice. Furthermore, SSNA1 is enriched on microtubule damage sites, occurring both naturally, as well as induced by the microtubule severing enzyme spastin. Finally, SSNA1 binding protects microtubules against spastin’s severing activity. Taken together, our results demonstrate that SSNA1 is both a potent microtubule-stabilizing protein and a novel sensor of microtubule damage; activities that likely underlie SSNA1’s functions on microtubule structures in cells.